In our latest Pα+ interview, Psychedelic Alpha Editor Josh Hardman sits down with Danielle Schlosser, co-founder and Chief Innovation Officer at mpathic, an AI-powered software platform that aims to enhance sponsor oversight of clinical trials, including any psychosocial support element as well as clinical outcome assessments. mpathic has attracted interest from psychedelic drug developers in…
